相关实验视频
Updated: Jul 5, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.8K
在癌症药物耐药性中利用EMT的功能:转移调节器确定化疗反应
Nasim Ebrahimi1, Mahdokht Sadat Manavi2, Ferdos Faghihkhorasani3
1Genetics Division, Department of Cell and Molecular Biology and Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, Iran.
Cancer metastasis reviews
|January 16, 2024
概括
皮质-介质细胞过渡 (EMT) 通过改变细胞行为来驱动瘤的扩散和治疗抵抗力. 了解EMT信号是改善癌症治疗结果的关键.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 发育生物学 发展生物学
背景情况:
- 表皮介质转变 (EMT) 是一种对发育至关重要的生物过程,并与瘤进展有关.
- EMT涉及细胞变化,使其能够迁移,从而导致癌症转移.
- 与纤维细胞相关的标记物,如FSP1,FGF,原和-SMA是EMT中介酶体表型的关键.
研究的目的:
- 探索EMT在癌症转移,治疗耐药性和复发中的作用.
- 研究上游信号通路 (EGF,TGF-β,Wnt) 对瘤EMT的影响.
- 了解瘤上皮细胞和纤维细胞之间的细胞交叉声对癌症进展的影响.
主要方法:
- 对EMT调节器的分析,包括ZEB1/2,Twist和Snail蛋白.
- 检查上游信号通路,如EGF,TGF-β和Wnt.
- 研究癌细胞与瘤微环境纤维细胞之间的细胞相互作用.
主要成果:
- 通过改变细胞微环境,EMT促进了瘤细胞的入侵和转移.
- 特定的EMT调节器和上游信号通路对于瘤进展至关重要.
- 瘤和脑膜细胞之间的细胞交叉对治疗反应和预后产生重大影响.
结论:
- EMT是癌症转移,耐治疗和复发的重要驱动因素.
- 针对EMT途径和细胞交叉通话提出了潜在的治疗策略.
- 对EMT信号的进一步研究对于推进癌症治疗至关重要.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Chemotaxis and Direction of Cell Migration
3.4K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.4K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

